- Project Summary
- Objectives
- Outcomes
- Team Members
Project Summary
Type 2 diabetes (T2D) has been shown to be reversible, remission to a non-diabetic state without need for medication, by substantial weight loss in UK Diabetes Remission Clinical Trial (DiRECT). This project aims to establish, evaluate, and generate pilot data to improve a novel low-cost, community-owned, intervention for weight loss, using traditional Nepalese meal patterns, based on the principles of the DiRECT. It is pilot research to examine the feasibility of a dietary intervention to reduce weight loss and achieve diabetes remission among 60 T2D patients of Metro Kathmandu Hospital. The intervention, a culturally adapted version of that used successfully in the UK DiRECT study, involves an initial ‘Total Diet Replacement’ phase, consuming three nutritionally complete meals of ~280kcal, total ~850kcal/day, to achieve >10kg (ideally >15kg) weight loss over 8-12 weeks, and then local dietary weight maintenance advice. The study outcome is remission of diabetes (HbA1c <48 mmol/mol) and secondary outcomes assessment include weight change, blood pressure, microalbuminuria, liver-function tests and ultrasound liver fat, physical activity, quality of life, diet habit, and quality of life. The amount of weight loss required for remission of T2D in Nepalese adults will be assessed (expected > 15kg for Europeans).
Objectives
To establish feasibility, refine protocol and methods, and establish pilot data for a power estimation to be able to mount a definitive randomized trial of a novel low-cost, dietary program for weight loss, prevention or remission of type 2 diabetes, and reduction of cardiometabolic risk factors.
Specific objectives:
- To evaluate change in HbA1c and weight loss due to dietary intervention
- Establish the accessibility, affordability, and acceptability of the Nepalese diet interventions for (i) inducing and (ii) maintaining weight loss.
- Evaluate the potential barriers and facilitators to diet change among the participants and ways to overcome them.
Outcomes
Type-II diabetes is a potentially reversible disease, with a dietary intervention replacing conventional drug treatments, is rising in the UK and worldwide, because of the DiRECT trial The expected outcomes are a decrease in weight of the participant with the given diet with a decrease in HbA1c without medication. This will cause the remission of diabetes.
Specific objectives:
- To evaluate change in HbA1c and weight loss due to dietary intervention
- Establish the accessibility, affordability, and acceptability of the Nepalese diet interventions for (i) inducing and (ii) maintaining weight loss.
- Evaluate the potential barriers and facilitators to diet change among the participants and ways to overcome them.
Team Members
Co-Principal Investigators: Prof. Michael Lean, Dr. Sujata Sapkota
Co-Investigators: Ms. Rashmi Maharjan, Dr. Abha Shrestha, Dr. Jyoti Bhattrai, Ms. Ruby Shrestha, Ms. Deepa Laxmi Makaju, Dr. Charoula Nikolaou, Dr. Binaya Bhattrai
Project Coordinators: Ms. Prasanna Rai
Supported by: All SAINT EDUCATIONAL TRUST (ASET)












